Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

19 results about "FLAG-tag" patented technology

FLAG-tag, or FLAG octapeptide, or FLAG epitope, is a polypeptide protein tag that can be added to a protein using recombinant DNA technology, having the sequence motif DYKDDDDK (where D=aspartic acid, Y=tyrosine, and K=lysine). It is an artificial antigen to which specific, high affinity monoclonal antibodies have been developed and hence can be used for protein purification by affinity chromatography and also can be used for locating proteins within living cells. It has been used to separate recombinant, overexpressed protein from wild-type protein expressed by the host organism. It can also be used in the isolation of protein complexes with multiple subunits, because its mild purification procedure tends not to disrupt such complexes. It has been used to obtain proteins of sufficient purity and quality to carry out 3D structure determination by x-ray crystallography.

An overexpression of a gene engineering rhizobium which codes purine nucleoside phosphorylase, construction method and application thereof

PendingCN123027255APlant noduleRhizobium sp.
This invention discloses a genetically engineered rhizobium strain overexpressing purine nucleoside phosphorylase, its construction method, and its applications, belonging to the fields of agricultural biotechnology and genetic engineering. This invention uses *Rhizobium fischeri* (Fragariae spp.) as the basis for its development. Sinorhizobium fredii CCBAU 45436 was used as the starting strain. The strain was introduced by introducing a sample containing the strain itself. rpoD Strong promoter sequences of genes, encoding purine nucleoside phosphorylases deoD The recombinant strain CCBAU 45436 deoD OE was obtained by using a recombinant plasmid composed of the gene sequence and the gene encoding a 3×Flag tag sequence. This recombinant strain has the accession number CGMCC No. 38578 at the China General Microbiological Culture Collection Center (CGMCC). This invention experimentally demonstrates that inoculation... deoD deoD deoD deoD deoD deoD deoD deoD Soybeans overexpressing the recombinant strain (CGMCC No. 38578) showed significantly better plant height and root nodule fresh weight than soybeans inoculated with unmodified wild-type rhizobium strains.
Owner:CHINA AGRI UNIV

Anti-flag antibodies

The present invention relates to antigen binding proteins and related fragments thereof for binding FLAG tags, production of the antigen binding proteins and fragments, and uses of the antibodies and fragments.
Owner:CURRUS BIOLOGICS PTY LTD

Method for extracting perfluorooctane sulfonic acid combined with receptor in cells based on membrane receptor

The invention discloses a G protein coupled receptor family membrane receptor GPR40 related to eukaryotic expression and glycometabolism effect, and a method for extracting and detecting the concentration of a compound combined with the GPR40 receptor in a cell based on the affinity of receptor protein. The detection method comprises the following steps: eukaryotically expressing a membrane receptor GPR40 protein with a Flag tag in a human embryonic kidney cell HEK293, and after perfluorooctane sulfonic acid (PFOS) is exposed, extracting and purifying a GPR40-PFOS compound in a cell lysis solution by utilizing Protein G magnetic beads and a Flag antibody; after uncombined PFOS is washed away by a cracking buffer solution containing a protease inhibitor, acetonitrile is added, and PFOS in the compound is extracted; and centrifuging and treating with a 0.22 mu m filter membrane, and detecting the concentration of the PFOS by using a high performance liquid chromatography-mass spectrometer (HPLC-MS / MS). The method can directly detect the concentration of PFOS combined with the GPR40 receptor, can be used for screening other perfluorinated compounds and environmental pollutants which potentially act on the GPR40 receptor to play a glycometabolism effect, can simplify the steps of effect-oriented analysis, and plays an important role in compound recognition and screening.
Owner:CHINA JILIANG UNIV

Application of corn ZmLOB gene in regulation and control of root development and low-phosphorus tolerance

The invention discloses application of a corn ZmLOB gene in regulation and control of root development and low-phosphorus tolerance, and belongs to the technical field of plant genetic engineering, the corn ZmLOB gene is a ZmLOB gene which is based on homologous recombination and is connected with an expression vector with a 3 * Flag tag; the overexpression ZmLOB gene is constructed by being connected with an expression vector with a 3 * Flag tag, the overexpression ZmLOB gene can regulate root system development and increase the content of inorganic phosphorus in root systems, corn is endowed with low-phosphorus stress tolerance, and a theoretical basis is provided for efficient phosphorus absorption and utilization of corn and excavation of low-phosphorus-tolerant germplasm resources.
Owner:SICHUAN AGRI UNIV

Eurytopic chlamydomonas reinhardtii expression vector based on PSAD promoter and 3*Flag tag as well as construction method and application of eurytopic chlamydomonas reinhardtii expression vector

The invention discloses an eurytopic chlamydomonas reinhardtii expression vector based on a PSAD promoter and a 3 * Flag tag as well as a construction method and application of the eurytopic chlamydomonas reinhardtii expression vector. The nucleotide sequence of the eurytopic chlamydomonas reinhardtii expression vector is shown as SEQ ID No.1; the vector comprises a PSAD promoter, a target gene insertion site EcoR V, a 3 * Flag tag at the 3'terminal, an rbcS2 terminator, a TUB2 promoter, a hygromycin B screening gene and an rbcS2 terminator. The construction method comprises the following steps: constructing a skeleton of a pHyg-PSAD-3Flag vector; constructing a sequence fragment fused with a 3 * Flag tag; and connecting the sequence fragment fused with the 3 * Flag tag with a plasmid skeleton fragment through T4 DNA (deoxyribonucleic acid) enzyme so as to construct the pHyg-PSAD-3Flag vector. According to the invention, the expression plasmid of the chlamydomonas pHyg-PSAD-3Flag can be used for efficiently screening algae strains capable of stably expressing target protein.
Owner:XUZHOU NORMAL UNIVERSITY +1

Method for endogenously extracting mycobacterium smegmatis protein nanocage

PendingUS20260002186A1Microorganism based processesNucleic acid vectorMycobacterium smegmatisTotal protein
A method for endogenously extracting a Mycobacterium smegmatis protein nanocage is provided. The method includes the following steps: introducing a recombinant plasmid containing a CFP29 gene and a 1×Flag affinity tag into a Mycobacterium smegmatis strain to obtain a recombinant Mycobacterium smegmatis strain; extracting a total protein solution of the recombinant Mycobacterium smegmatis strain, and subjecting the total protein solution of the recombinant Mycobacterium smegmatis strain to Flag tag affinity column chromatography purification to obtain a crude extract of the Mycobacterium smegmatis protein nanocage; and subjecting the crude extract of the Mycobacterium smegmatis protein nanocage to gel exclusion chromatography purification to obtain a pure product of the Mycobacterium smegmatis protein nanocage. The method is simple to operate and convenient to implement during extraction and purification, and an obtained Mycobacterium smegmatis background protein nanocage has a high yield, excellent purity, and stable properties.
Owner:NANKAI UNIV

Purification method of mycobacterium-derived nanocarrier protein

The present disclosure provides a purification method of a Mycobacterium-derived nanocarrier protein, and belongs to the technical field of protein purification. In the present disclosure, the purification method includes the following steps: providing an Escherichia coli total protein solution, where the Escherichia coli total protein solution includes a Mycobacterium-derived nanocarrier protein, and the Mycobacterium-derived nanocarrier protein is fused with a 1×Flag tag at a C-terminus of a subunit; subjecting the Escherichia coli total protein solution to Flag tag affinity chromatography purification to obtain a crude extract of the Mycobacterium-derived nanocarrier protein; and subjecting the crude extract of the Mycobacterium-derived nanocarrier protein to gel exclusion chromatography purification to obtain a pure product of the Mycobacterium-derived nanocarrier protein. The purification method has simple and easy operations.
Owner:NANKAI UNIV

A method for constructing a mitochondrial RNA m1A demethylation editing fusion protein based on the CRISPR-Cas13b system and its application in liver cancer.

PendingCN123027284AMitochondrial transcriptionTargeted therapy
The application belongs to the technical field of biological medicine. In view of the fact that the prior art lacks a method for specifically targeting mitochondria RNA (mtRNA) in living cells for site-precision m 1 A editing tool, the application discloses a plasmid system for mtRNA-targeted m 1 A demethylation editing: pcDNA3.1(+)‑F1β‑dCas13b‑ALKBH3‑Flag and PspCas13b COX1‑gRNA crRNA. The former encodes a mitochondrial targeting sequence F1β and a fusion protein (with a Flag tag) of dCas13b and ALKBH3, which can be expressed in mammalian cells to realize m 1 A demethylation regulation of specific mRNA; the latter expresses a specific crRNA for a mitochondrial COX1 transcript, which is used to guide the precise targeting of the dCas13b system. The combination of the two plasmids constitutes a highly efficient and specific mtRNA m 1 A demethylation regulation system, and meanwhile, the application verifies the application of the targeting editing tool in liver cancer at the cell level, which provides a new tool for mitochondrial epitranscriptome research and liver cancer targeted therapy.
Owner:SUN YAT SEN UNIV

Recombinant lactobacillus paracasei for fusion expression of swine trefoil factor 3 and epidermal growth factor as well as construction method and application of recombinant lactobacillus paracasei

The invention discloses recombinant lactobacillus paracasei for fusion expression of a swine trefoil factor 3 and an epidermal growth factor as well as a construction method and application of the recombinant lactobacillus paracasei, and belongs to the technical field of veterinary medicines. The recombinant lactobacillus paracasei contains recombinant plasmids capable of expressing fusion protein of a swine trefoil factor 3 and an epidermal growth factor. Wherein the porcine trefoil factor 3 is connected with the epidermal growth factor through a rigid Linker, the amino terminal of the fusion protein is further connected with a signal peptide SP sequence, the carboxyl terminal of the fusion protein is connected with a flag tag, and the structure of the obtained fusion protein is SP-pTFF3-rigid Linker-pEGF-flag. According to the invention, TFF3 and EGF are fused into a single protein through genetic engineering, the problem of proportion control of traditional two-factor combined administration is solved, and'repair-regeneration 'dual-channel synergy is realized by utilizing a spatial proximity effect. In-vivo experiments prove that the recombinant bacterium obtained by the invention not only can repair intestinal mucosa, but also can achieve the purpose of treating the inflammatory bowel disease by regulating cell factors such as IL-10 / IL-6 and the like to balance an inflammatory microenvironment.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Construction method and application of CAG promoter specific driving LSL-RCAN1-P2A-EGFP-Flag tag expression animal model

PendingCN121472323AVectorsAntibody mimetics/scaffoldsRCAN1 GenePromoter
The invention provides a construction method and application of an animal model for specifically driving LSL-RCAN1-P2A-EGFP-Flag tag to express by using a CAG (chorionic gonadotropin) promoter. The method is realized by inserting a CAG promoter sequence, an LSL sequence, an RCAN1 gene coding sequence, an EGFP sequence, a Flag tag sequence and a PolyA sequence into a Rosa26 site of a mouse genome. When the RCAN1-2A-EGFP gene is hybridized with a mouse with tissue or cell specific expression CRE enzyme, a Stop sequence between loxP sites can be cut off, so that overexpression of the RCAN1-2A-EGFP protein driven by a tissue or cell specific CAG promoter is realized, the translated protein can be separated into two independent proteins for performing functions, and an animal model is provided for researching the function of the RCAN1 in specific tissue or cell.
Owner:SHANGHAI CITY PUDONG NEW AREA GONGLI HOSPITAL

Method for rescuing depleted immune cells

The present invention relates to compositions and methods for preventing or rescuing the depletion of immune effector cells, in particular CAR T cells. The compositions and methods comprise bispecific polypeptides having a first antigen-binding protein that specifically binds to an antigen expressed on an antigen presenting cell (e.g., CD40), and a second antigen-binding protein that specifically binds to an antigen on the immune effector cell (e.g., a FLAG tag on a CAR T cell).
Owner:CURRUS BIOLOGICS PTY LTD

Construction method and application of IER2-Flag gene knock-in mouse model

The invention discloses a construction method and application of an IER2-Flag gene knock-in mouse model, and the construction method comprises the following steps: determining a target site of an IER2 gene to be knocked in a mouse, and designing sgRNA with a sequence as shown in SEQ ID No: 2; the method comprises the following steps: carrying out recombination on double-stranded sgRNA formed by annealing and CRISPR-Cas9 plasmid PX459, and constructing a PX459-sgRNA recombinant plasmid of which the sequence is as shown in SEQ ID No: 3-4; the method comprises the following steps: by taking a recombinant plasmid as a template, carrying out PCR (Polymerase Chain Reaction) amplification on a double-stranded DNA (Deoxyribose Nucleic Acid) fragment of a T7 promoter sequence + sgRNA + tracr RNA, and carrying out in-vitro transcription to obtain single-stranded sgRNA + tracr RNA, a single-chain sgRNA + tracr RNA, a Donor sequence containing a 3 * Flag tag and Cas9 Protein are co-injected into a male pronucleus of a mouse fertilized egg, an F0-generation IER2-Flag gene knock-in mouse can be obtained until an F3-generation IER2-Flag gene knock-in mouse is obtained, and the IER2-Flag gene knock-in mouse model is obtained. According to the invention, the expression of the Flag tag is detected for the first time to further identify that the IER2 protein is continuously and strongly expressed in the enamel cell, and an important animal model is provided for the research on revealing a mechanism for regulating and controlling enamel mineralization by the IER2 gene.
Owner:FUJIAN NORMAL UNIV

A method for constructing a TrpA1-3xFLAG-P2A-iCre gene knock-in mouse

PendingCN122326685AExonRecombinase
This invention discloses a method for constructing a TrpA1-3×FLAG-P2A-iCre gene knock-in mouse. A fragment containing a 3×FLAG tag, a P2A sequence, and an iCre recombinase sequence is inserted into the 27th exon region of the mouse TrpA1 gene using a CRISPR / Cas9 system, achieving genetic labeling and Cre functionalization in TrpA1-expressing cells. The donor vector provided by this invention contains a 5' homologous arm and a 3' homologous arm that are homologous to the TrpA1 genome sequence. Stably inherited knock-in mice are obtained by microinjecting the CRISPR / Cas9 system and the donor vector into fertilized eggs.
Owner:ZHEJIANG UNIV

Construction method and application of ST cell strain for stable overexpression of RPSA

The invention discloses a construction method and application of an ST cell strain capable of stably overexpressing RPSA, the method comprises the following steps: amplifying an RPSA coding sequence, adding a Flag tag to a carboxyl terminal, cloning the RPSA coding sequence to a pIRES-puromycin vector to obtain a pIRES-puromycin-RPSA-Flag recombinant plasmid, transfecting an ST cell, screening by using puromycin with a proper concentration, then carrying out monoclonal selection, and finally identifying the monoclonal cell strain by using Westernbloting, thereby obtaining the ST cell strain capable of stably overexpressing RPSA. The invention further discloses application of the ST cell strain, the ST cell strain with stable overexpression of RPSA constructed by the invention can be used for amplification of PRV virus, and can improve the PRV virus titer so as to improve the vaccine yield, and a new cell matrix is provided for efficient production of PRV vaccines.
Owner:ZHEJIANG UNIV OF TECH SHAOXING BIOMEDICAL RES INST CO LTD +2

Porcine epidemic diarrhea virus mRNA vaccine and construction method thereof

The invention provides a porcine epidemic diarrhea virus mRNA vaccine and a construction method thereof. The mRNA vaccine is synthesized from a signal peptide containing 5 'UTR and human PLAT, a porcine epidemic diarrhea virus S protein truncation (amino acids at 477th to 629th sites of PEDV S protein), a Flag tag, a termination codon, 3' UTR and poly (A) tail nucleic acid. According to the invention, lipid nanoparticles are used as a delivery system of mRNA. The constructed mRNA vaccine is intramuscularly injected into a 6-8-week-old BALB / c mouse, the mRNA vaccine can remarkably improve IgG titer in serum of the immunized mouse, induce humoral immunity and generate a specific antibody aiming at a target protein, and also can induce cellular immunity, so that an effective technical means is provided for prevention and control of a new variant strain.
Owner:CHINA AGRI UNIV

Method for detecting SUMOylation modification of tomato protein

The invention relates to the technical field of biology, in particular to a method for detecting SUMOylation modification of tomato protein. The method comprises the following steps: preparing-E2 and + E2 type Escherichia coli competent cells, transferring a substrate protein of a tomato to be detected containing a fusion tag into the-E2 and + E2 type competent cells, the-E2 type competent cells being a control group, and the + E2 type competent cells being an experimental group; and inducing protein expression, and comparing the signal intensity and band migration situation of Flag tag substrate protein in-E2 and + E2 sample mycoprotein to judge whether the tomato substrate protein to be detected is subjected to SUMO modification or not. The problem that substrate protein SUMO modification detection is difficult due to complex metabolism regulation in tomato cells is effectively solved.
Owner:ZHOUKOU NORMAL UNIV

Enhanced exosome for expressing antigen-targeted antibody as well as preparation method and application of enhanced exosome

The invention belongs to biological medicines, and discloses an enhanced exosome for expressing an antigen-targeted antibody as well as a preparation method and application of the enhanced exosome. An antigen targeting antibody is expressed on the surface of the exosome, and the antigen targeting antibody comprises: 1) a signal peptide; (2) a histidine tag (His-tag) and a Flag tag; 3) a single-chain antibody region of a targeted antigen; 4) a hinge area; 5) transmembrane area; and 6) a fluorescent protein. The enhanced exosome is prepared by a gene engineering method, and surface modification of the exosome is realized by utilizing a lentiviral vector, so that the enhanced exosome has definite antigen targeting property and preparation sustainability.
Owner:GUANGDONG PANGUARD CELL BIOLOGICAL TECH CO LTD

Assay with an igfbp-1 peptide or protein to predict severe acute kidney injury

An assay for predicting severe acute kidney injury is disclosed. The assay detects cleavage of a peptide or protein with an internal sequence that mimics all or some of the central linker region of insulin-like growth factor binding protein 1. The amount of cleavage of the peptide or protein predicts the likelihood that a patient will develop severe acute kidney injury. The peptide or protein used in the assay may contain a terminal His tag and a terminal Flag tag to immobilize the amino-terminal and carboxy-terminal ends of the peptide on a test strip of the assay after cleavage.
Owner:BIOVENTURES LLC

CRISPR / dCas9 vector for improving BnNAC022 gene expression as well as construction method and application of CRISPR / dCas9 vector

The invention relates to a CRISPR / dCas9 (clustered regularly interspaced short palindromic repeats / dCas9) vector for improving BnNAC022 gene expression as well as a construction method and application of the CRISPR / dCas9 vector. The CRISPR / dCas9 vector is a CRISPR-SL-U6-26-TG1-TG2 vector, the nucleotide sequence of the CRISPR / dCas9 vector is shown as SEQ ID NO.7, and the CRISPR / dCas9 vector contains an expression cassette with two cores; the expression box 1 comprises an arabidopsis thaliana U6-26 promoter, a target spot 1, an sgRNA2.0 support sequence, an At-tRNAGly coding sequence, a target spot 2 and an sgRNA2.0 support sequence in sequence from the 5 '-3' end; and the expression box 2 sequentially comprises a constitutive promoter, a 3 * Flag tag coding sequence, a first SV40 NLS, a dCas9 coding gene, an NLS nuclear localization signal, a VP64 coding gene, a coding gene of self-splitting polypeptide T2A, an MS2 coding gene, a second SV40 NLS, a P65 coding gene, an HSF1 coding gene and an NOS transcription terminator from the 5 '-3' end. The recombinant vector CRISPR-SL-U6-26-TG1-TG2 constructed by the invention is an activation vector of a targeted BnNAC022 gene promoter, so that the expression level of the BnNAC022 gene in the brassica napus can be remarkably improved, and the aphid resistance of the brassica napus can be enhanced.
Owner:安徽省农业科学院